Colgate Palmolive (India) Ltd.
NSE: COLPALColgate Palmolive (India) Ltd.: A 30-second snapshot
Colgate-Palmolive India (COLPAL) is an oral-care-focused FMCG company trading at 2146.60, a PE of 44.3x, with a 22.5% profit margin and a dividend yield of 2.38%. The stock is 20.17% below its 52-week high and sits marginally below its 200-DMA, while 5-year earnings and revenue growth have been near flat at 0.3% and 1.7% respectively. Debt-to-equity of 3.791 stands out relative to FMCG peers, and the quality score of 44 places it fifth among six comparable companies.
P/E
44.3
Forward P/E
40.3
ROE
—
Debt / Equity
3.79
Profit Margin
+22.5%
Div. Yield
+2.4%
5Y ROE > 15%
4/5
5Y FCF > 0
4/5
Quality
54/100
News
3 headlines · 0 positive · 0 negative
Colgate-Palmolive (India) stock (INE259A01022): Steady oral care leader in India's consumer market - AD HOC NEWS
AD HOC NEWS
13 Best FMCG Stocks In India May 2026 | Top Performing FMCG Companies - Samco
Samco
Colgate-Palmolive (India) Backs IEPF's 'Saksham Niveshak' Drive to Clear Unclaimed Dividends - TipRanks
TipRanks
Recent context
- ·News flow over the analysis window was sparse -- 3 articles, all rated neutral -- covering general FMCG sector features and a dividend unclaimed-share initiative; no material corporate events or earnings updates were captured.
- ·The company supported the IEPF Saksham Niveshak drive to clear unclaimed dividends, a governance-aligned action with no direct financial impact reported.
- ·With 27 analysts covering the stock but no consensus rating figure available in the current data, the breadth of sell-side attention is notable while the aggregate direction of that coverage cannot be characterised from the current dataset.
Strengths
- +Profit margin of 22.5% is high in absolute terms, consistent with a branded consumer-staples business that can sustain pricing power in a commoditised oral-care market.
- +FCF was positive in 4 of 5 years with a consistency score of 74, indicating that earnings convert reliably into cash despite stagnant growth rates.
- +PE of 44.3x is the second-lowest among six FMCG peers (ITC at 19.0x is the only lower-rated name), and forward PE of 40.3x reflects a modest compression in the market expectation.
- +Debt trend is described as falling, suggesting the elevated D/E of 3.791 may be in the process of improvement rather than deterioration.
Weaknesses
- −Debt-to-equity of 3.791 is materially higher than the FMCG sector norm; peers such as Hindustan Unilever and Nestle India carry far lower leverage, making this a clear balance-sheet outlier.
- −5-year earnings growth of 0.3% and revenue growth of 1.7% indicate that the business has delivered near-zero real expansion over the past half-decade.
- −Price is down 16.01% over 12 months and 20.17% below the 52-week high; the stock sits below its 200-DMA (2155.88) at 2146.60, with the medium-term trend still negative.
- −Quality score of 44 ranks 5th of 6 FMCG peers, below NESTLEIND (61), HINDUNILVR (58), BRITANNIA (50), and TATACONSUM (45).
Open questions
- ?Does the elevated debt-to-equity of 3.791 reflect a specific capital structure choice (such as royalties or intercompany arrangements with the Colgate-Palmolive global parent) or a structural funding constraint, and what is management stated trajectory for leverage?
- ?Given that FCF has been positive in 4 of 5 years but earnings growth over 5 years is only 0.3%, where is the generated cash being deployed -- dividends, royalties to parent, capex, or balance-sheet reduction?
- ?How has COLPAL oral-care volume and market-share trend evolved relative to private-label and regional competitors over the past 3 years, and is flat revenue growth a sector-wide phenomenon or company-specific?
- ?At a PE of 44.3x against near-zero 5-year earnings growth, what growth rate assumption would be needed to justify the current multiple relative to peers such as ITC at 19x or Hindustan Unilever at 50x?
Peer comparison: FMCG
Ranks 5 of 6 on quality| Symbol | Name | P/E | ROE | Quality |
|---|---|---|---|---|
| COLPAL | Colgate Palmolive (India) Ltd.You're viewing | 44.3 | — | 44 |
| Industry avg | across 5 peers | 55.8 | +39.5% | 52 |
| NESTLEIND | Nestle India Ltd. | 79.0 | +76.3% | 61 |
| HINDUNILVR | Hindustan Unilever Ltd. | 50.3 | +21.6% | 58 |
| BRITANNIA | Britannia Industries Ltd. | 51.3 | +53.3% | 50 |
| TATACONSUM | Tata Consumer Products Ltd. | 79.1 | +6.9% | 45 |
| ITC | ITC Ltd. | 19.0 | — | 44 |
Technical state
Current price
₹2,146.60
SMA 50
₹2,040.58
SMA 200
₹2,155.88
RSI (14)
56.8 (neutral)
From 52w high
-20.2%
1Y return
-16.0%
3M return
-1.7%
50-DMA
Above
200-DMA
Below
Algorithmic support levels
Algorithmic resistance levels
Risk flags
- highDebt-to-equity of 3.791 is well above the FMCG sector norm; peers such as Hindustan Unilever and Nestle India typically carry minimal leverage, making COLPAL an outlier on balance-sheet risk within the sector.
- mediumPrice is 20.17% below the 52-week high and down 16.01% over the past 12 months; the stock sits below its 200-DMA (2155.88) at 2146.60, indicating the medium-term price trend remains negative even as it has recovered above the 50-DMA.
- medium5-year earnings growth of 0.3% and revenue growth of 1.7% indicate near-stagnant top- and bottom-line expansion over a half-decade, despite a consistency score of 74 and 4 of 5 years of positive FCF.
- lowCOLPAL ranks 5th of 6 peers on quality score (44), behind NESTLEIND (61), HINDUNILVR (58), BRITANNIA (50), and TATACONSUM (45), placing it in the bottom tier of its FMCG peer group on composite quality.
- lowAnalyst mean rating is unavailable despite 27 analysts covering the stock; ROE for COLPAL and 1-year price-change data for all 5 peers are also null, limiting several comparative rankings.
Cross-section contradictions
- Consistency score of 74 and positive FCF in 4 of 5 years point to durable operational quality, yet 5-year earnings growth of 0.3% shows that cash generation has not translated into meaningful profit expansion.
- Price has recovered above the 50-DMA (2040.58) with RSI at 56.75, yet remains below the 200-DMA (2155.88) and is down 16.01% over 12 months -- short-term recovery coexisting with a longer-term price decline.
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.
Fundamentals & technicals: refreshed 25 Jun 2026 · refreshed daily at 01:00 IST
AI synthesis (narrative, snapshot, strengths/weaknesses, peer ranking): generated 15 May 2026 · rotates through NIFTY 500 every ~5 days